NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
Press Release
Read More
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
Literature
Read More
NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017
Press Release
Read More
Integrated Analysis of MicroRNA, mRNA, and Protein Expression Utilizing MultiOmyx™ and NanoString™ from Formalin-Fixed Paraffin-Embedded Lung, Head and Neck, Breast, and Melanoma Tumors
Literature
Read More
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia
Literature
Read More
Development and validation of automated flow cytometry system for the diagnosis and prediction of molecular abnormalities in myelodysplastic syndrome
Literature
Read More